Camacho X - Search Results

1

177Lu-DOTA-Bevacizumab: Radioimmunotherapy Agent for Melanoma.

Camacho X, Calzada V, Fernandez M, Alonso O, Chammas R, Riva E, Gambini JP, Cabral P. Camacho X, et al. Curr Radiopharm. 2017;10(1):21-28. doi: 10.2174/1874471009666161010155246. Curr Radiopharm. 2017. PMID: 27748184

2

Synthesis of 99mTc-nimotuzumab with tricarbonyl ion: in vitro and in vivo studies.

Garcia MF, Camacho X, Calzada V, Fernandez M, Porcal W, Alonso O, Gambini JP, Cabral P. Garcia MF, et al. Among authors: camacho x. Curr Radiopharm. 2012 Jan;5(1):59-64. doi: 10.2174/1874471011205010059. Curr Radiopharm. 2012. PMID: 22074480

3

Synthesis and evaluation of (99m)Tc chelate-conjugated bevacizumab.

Camacho X, García MF, Calzada V, Fernández M, Porcal W, Alonso O, Gambini JP, Cabral P. Camacho X, et al. Curr Radiopharm. 2013 Mar;6(1):12-9. doi: 10.2174/1874471011306010003. Curr Radiopharm. 2013. PMID: 23035645

4

[(99m)Tc(CO)(3)]-radiolabeled bevacizumab: in vitro and in vivo evaluation in a melanoma model.

Camacho X, García MF, Calzada V, Fernández M, Chabalgoity JA, Moreno M, Barbosa de Aguiar R, Alonso O, Gambini JP, Chammas R, Cabral P. Camacho X, et al. Oncology. 2013;84(4):200-9. doi: 10.1159/000338961. Epub 2013 Jan 15. Oncology. 2013. PMID: 23328435

5

Microwave-assisted synthesis of HYNIC protected analogue for 99mTc labeled antibody.

García MF, Calzada V, Camacho X, Goicochea E, Gambini JP, Quinn TP, Porcal W, Cabral P. García MF, et al. Among authors: camacho x. Curr Radiopharm. 2014;7(2):84-90. doi: 10.2174/1874471007666141128160449. Curr Radiopharm. 2014. PMID: 25429778 Review.

6

Technetium-99m- or Cy7-Labeled Rituximab as an Imaging Agent for Non-Hodgkin Lymphoma.

Camacho X, Machado CL, García MF, Gambini JP, Banchero A, Fernández M, Oddone N, Bertolini Zanatta D, Rosal C, Buchpiguel CA, Chammas R, Riva E, Cabral P. Camacho X, et al. Oncology. 2017;92(4):229-242. doi: 10.1159/000452419. Epub 2017 Feb 15. Oncology. 2017. PMID: 28196364

7

Tocilizumab Labeling with 99mTechnetium via HYNIC as a Molecular Diagnostic Agent for Multiple Myeloma.

Camacho X, Machado CL, García MF, Fernández M, Oddone N, Benech J, Gambini JP, Cerecetto H, Chammas R, Cabral P, Riva E. Camacho X, et al. Anticancer Agents Med Chem. 2017;17(9):1267-1277. doi: 10.2174/1871520617666170213144917. Anticancer Agents Med Chem. 2017. PMID: 28270081

8

99mTechnetium- or Cy7-Labeled Fab(Tocilizumab) as Potential Multiple Myeloma Imaging Agents.

Camacho X, Perroni C, Machado CL, de Godoi Carneiro C, de Souza Junqueira M, Faria D, García MF, Fernández M, Oddone N, Benech J, Buchpiguel CA, Cerecetto H, Chammas R, Riva E, Cabral P, Gambini JP. Camacho X, et al. Anticancer Agents Med Chem. 2021;21(14):1883-1893. doi: 10.2174/1871520621999210104181238. Anticancer Agents Med Chem. 2021. PMID: 33397271

9

Synthesis of hydrophilic HYNIC-[1,2,4,5]tetrazine conjugates and their use in antibody pretargeting with ^99mTc.

García MF, Gallazzi F, Junqueira MS, Fernández M, Camacho X, Mororó JDS, Faria D, Carneiro CG, Couto M, Carrión F, Pritsch O, Chammas R, Quinn T, Cabral P, Cerecetto H. García MF, et al. Among authors: camacho x. Org Biomol Chem. 2018 Jul 25;16(29):5275-5285. doi: 10.1039/c8ob01255e. Org Biomol Chem. 2018. PMID: 29974915

10

Increasing the potency of neutralizing single-domain antibodies by functionalization with a CD11b/CD18 binding domain.

Rossotti MA, González-Techera A, Guarnaschelli J, Yim L, Camacho X, Fernández M, Cabral P, Leizagoyen C, Chabalgoity JA, González-Sapienza G. Rossotti MA, et al. Among authors: camacho x. MAbs. 2015;7(5):820-8. doi: 10.1080/19420862.2015.1068491. MAbs. 2015. PMID: 26192995 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

50 results

Search Page